Global Bio Banks Market Supplier, Competitors and Manufacturers to 2017-2022 Forecast
Global Bio Banks Market is expected to grow at a significant CAGR in the estimated
period. A bio-repository which preserves biological specimen for research is
known as a biobank. Bio-samples form a significant part in research and
development events linked with development and drug discovery. Biobanks provide
certain assistance in obtaining solutions to diseases including nucleotide
polymorphisms, through genome association studies. Increase in occurrence of
various chronic diseases across the globe including cancer, neurovascular,
cardiovascular, respiratory and diabetes disease. These diseases are caused by
various activities such as smoking, alcohol consumption, unhealthy diets, lack
of physical activity and genetic disorders. These factors are expected to
increase the demand for biobanks in need for advanced and innovative medical
drugs with high performance and high healing effect.
Government funding particularly in healthcare sector can be
attributed as the key factor for the Bio Banks Market growth in emerging
economies. High investment in research and development is necessary to develop
new drugs and offer better healthcare to the patients and for Public
awareness. However, the Bio Banks Market
has been face challenges from various factors including lack of quality and standardized
bio specimens Failure rate of clinical trials also act as a major factor
restraining the growth of market. High cost incurred in such failures is
expected to decrease the demand for biobanks.
However, researchers and scientists are continuously innovating
and developing stem cell human tissue samples to carry out pre-clinical trials.
These initiatives are expected to provide growth opportunities for the market
over the forecast period. Growing demand for stem cell and tissue samples is
expected to propel the market growth for the biobanks market. In addition,
increasing adoption of stem cell procedures coupled with application of
initiatives for standardization of biobanking procedures is anticipated to boost
the Bio Banks Market growth On the basis of product type, the global market has
been segmented into bio preservation media and equipment. The bio preservation
equipment is further classified into Temperature Control Systems, Centrifuges,
Incubators, Alarms & Monitoring Systems, and Accessories. Temperature
control systems is expected to have the largest share in the global market
Controlling and monitoring temperature for preserved bio specimens is
considered to be very critical. It is crucial for sample viability and quality.
Minor temperature variations during transit of these samples from one region to
another can affect the entire research.
Accessories segment is expected to witness significant growth rate
over the forecast period owing to increasing need for use of devices including
data logger, transmitter, splitter, and RTD. These products help in control and
maintain the bio bank temperature and sensors. On the basis of bio specimen,
the Bio Banks Market has been segmented into Stem Cells, Human Tissue Samples, and
Organ. Human tissue and stem cells are expected to grow at a significant growth
rate owing to the increasing demand and storage of human tissues for research
and transplantation. Establishment of many bio banks across the globe is
expected to grow tissue banks. On the basis of application type, the bio bank
market has been segmented into Therapeutic, Research Applications, and Clinical
Trials. Therapeutic is expected to have the largest market share. Therapeutic
is the branch of medicine concerned with the treatment of disease and the
action of remedial agents. With the introduction of advanced personalized
medicine and bio therapeutics, biorepositories have transformed from basic
storage facilities to efficient biobanks.
On the basis of end use segment, the global market has been
segmented into biobanks, gene banks, and hospitals. Gene and biobanks are
expected to have the largest market share owing to use of these specimen and
preserved samples for research and development in hospitals they are widely
used for Disease Phenotyping. The global Bio Banks Market can be segmented into different sectors including population
banking, commercial biobanks, stem cell banking, academic collections, private
cord banking, along with other facilities such as RNA and DNA storage.
North America is expected to be the key regional market followed
by Europe. Increasing number of research initiatives and also presence of key
biobank facilities in this region is expected to boost the overall market over
the forecast period. Huge demand for bio banks grom regions including U.K,
Germany, Italy and Netherlands is expected to propel the Bio Banks Market in
Europe. Key players in the Bio Banks
Market are Bristol-Myers Squibb, Abbott Laboratories, Roche Ltd., Johnson and
Johnson, Affymetrix and Teva Pharmaceuticals. Other participants include Tecan
AG, New Brunswick Scientific Co, TAP Biosystems, and BioKryo GmbH
Get
a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/bio-banks-market/request-sample
Comments
Post a Comment